Literature DB >> 24067661

Amyloid and inflammation.

Peter D Gorevic1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24067661      PMCID: PMC3799384          DOI: 10.1073/pnas.1315112110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

1.  Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis.

Authors:  Barbara Kluve-Beckerman; Joyce Hardwick; Lijing Du; Merrill D Benson; Brett P Monia; Andrew Watt; Rosanne M Crooke; Adam Mullick
Journal:  Amyloid       Date:  2011-08-10       Impact factor: 7.141

2.  Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene.

Authors:  M Botto; P N Hawkins; M C Bickerstaff; J Herbert; A E Bygrave; A McBride; W L Hutchinson; G A Tennent; M J Walport; M B Pepys
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

3.  AA amyloidosis: Mount Sinai experience, 1997-2012.

Authors:  Daniel Bunker; Peter Gorevic
Journal:  Mt Sinai J Med       Date:  2012 Nov-Dec

4.  SAA does not induce cytokine production in physiological conditions.

Authors:  Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Nancy R Webb; Frederick C de Beer
Journal:  Cytokine       Date:  2012-11-17       Impact factor: 3.861

5.  Transmission of circulating cell-free AA amyloid oligomers in exosomes vectors via a prion-like mechanism.

Authors:  Masayoshi Tasaki; Mitsuharu Ueda; Sho Ochiai; Yuko Tanabe; Sho Murata; Yohei Misumi; Yu Su; Xuguo Sun; Satoru Shinriki; Hirofumi Jono; Makoto Shono; Konen Obayashi; Yukio Ando
Journal:  Biochem Biophys Res Commun       Date:  2010-08-31       Impact factor: 3.575

6.  Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study.

Authors:  S Inoue; P G Hultin; W A Szarek; R Kisilevsky
Journal:  Lab Invest       Date:  1996-06       Impact factor: 5.662

7.  Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.

Authors:  Saipraveen Srinivasan; Sanket Patke; Yun Wang; Zhuqiu Ye; Jeffrey Litt; Sunit K Srivastava; Maria M Lopez; Dmitry Kurouski; Igor K Lednev; Ravi S Kane; Wilfredo Colón
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

8.  Adenoviral expression of murine serum amyloid A proteins to study amyloid fibrillogenesis.

Authors:  M S Kindy; A R King; J Yu; C Gerardot; J Whitley; F C de Beer
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

9.  Pathogenetic mechanisms of amyloid A amyloidosis.

Authors:  J Paul Simons; Raya Al-Shawi; Stephan Ellmerich; Ivana Speck; Samrina Aslam; Winston L Hutchinson; Palma P Mangione; Petra Disterer; Janet A Gilbertson; Toby Hunt; David J Millar; Shane Minogue; Karl Bodin; Mark B Pepys; Philip N Hawkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

10.  Endogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different Receptors.

Authors:  Karin Christenson; Lena Björkman; Sofie Ahlin; Maja Olsson; Kajsa Sjöholm; Anna Karlsson; Johan Bylund
Journal:  Front Immunol       Date:  2013-04-22       Impact factor: 7.561

View more
  9 in total

1.  Longitudinal study of experimental induction of AA amyloidosis in mice seeded with homologous and heterologous AA fibrils.

Authors:  Naeem Muhammad; Tomoaki Murakami; Yasuo Inoshima; Naotaka Ishiguro
Journal:  Inflamm Res       Date:  2016-05-10       Impact factor: 4.575

2.  Hepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartan.

Authors:  Sonia Villapol; Dmitry Kryndushkin; Maria G Balarezo; Ashley M Campbell; Juan M Saavedra; Frank P Shewmaker; Aviva J Symes
Journal:  Am J Pathol       Date:  2015-10       Impact factor: 4.307

3.  Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice.

Authors:  N Muhammad; T Murakami; Y Inoshima; N Ishiguro
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

4.  Serum Amyloid A is Expressed in the Brain After Traumatic Brain Injury in a Sex-Dependent Manner.

Authors:  Sirena Soriano; Bridget Moffet; Evan Wicker; Sonia Villapol
Journal:  Cell Mol Neurobiol       Date:  2020-02-14       Impact factor: 5.046

Review 5.  Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses.

Authors:  Yan-Mei Huang; Xue-Zhi Hong; Jian Shen; Li-Jun Geng; Yan-Hong Pan; Wei Ling; Hai-Lu Zhao
Journal:  Front Immunol       Date:  2020-01-09       Impact factor: 7.561

6.  Preparing for Life: Plasma Proteome Changes and Immune System Development During the First Week of Human Life.

Authors:  Tue Bjerg Bennike; Benoit Fatou; Asimenia Angelidou; Joann Diray-Arce; Reza Falsafi; Rebecca Ford; Erin E Gill; Simon D van Haren; Olubukola T Idoko; Amy H Lee; Rym Ben-Othman; William S Pomat; Casey P Shannon; Kinga K Smolen; Scott J Tebbutt; Al Ozonoff; Peter C Richmond; Anita H J van den Biggelaar; Robert E W Hancock; Beate Kampmann; Tobias R Kollmann; Ofer Levy; Hanno Steen
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

7.  Oral amyloidosis: A case report and diagnostic algorithm.

Authors:  Sudip Indu; Indranil Deb Roy; Rohit Tewari; Suman Pramanik
Journal:  J Oral Maxillofac Pathol       Date:  2022-01-11

8.  A Tongue Lesion as a Sign of a Systemic Disease.

Authors:  Chrysoula I Liakou; Joan Koh; Antonios Tsimpidakis; Katrina Rios; Charalabos Paskalis; Athanasios Pipilis; Dimitrios Kantianis; Thomas Georgiadis; Evangelia Razis
Journal:  Case Rep Med       Date:  2016-03-22

9.  Transthyretin Cardiac Amyloidosis and Aortic Stenosis: Connection and Therapeutic Implications.

Authors:  Jorge Penalver; Maxwell Ambrosino; Hee D Jeon; Akanksha Agrawal; Napatt Kanjanahattakij; Marie Pitteloud; Jessica Stempel; Aman Amanullah
Journal:  Curr Cardiol Rev       Date:  2020
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.